Total Funding
$365 Million
Total Rounds
3
First Raise
Jun 12, 2023
Latest Raise
Jan 8, 2026
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 1/8/2026 | Series C | $75 million | Life Sciences at Goldman Sachs Alternatives |
2 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics